Renin and Prorenin Depleted Human Plasma

<strong>Renin and Prorenin Depleted Human Plasma</strong>_x000D_ <strong>Catalog number:</strong> B2012498_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Plasma_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Renin/Prorenin Double Depleted Human Plasma_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Azizi M, Chatellier G, Guyene TT, Ménard J. Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan J Hypertens. 1999 Apr;17(4):561-8._x000D_ 2: Krishna GG, Kapoor SC. Potassium depletion exacerbates essential hypertension Ann Intern Med. 1991 Jul 15;115(2):77-83._x000D_ 3: Azizi M, Ménard J, Bissery A, Guyenne TT, Bura-Rivière A, Vaidyanathan S, Camisasca RP. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption J Am Soc Nephrol. 2004 Dec;15(12):3126-33._x000D_ 4: Monge M, Paquet V, Bergerot D, Zhygalina V, Blanchard A. Dose-effect relationship of perindopril 10, 14 and 20mg assessed by urine and plasma AcSDKP levels in mildly sodium-depleted healthy volunteers Int J Cardiol. 2016 Nov 1;222:648-653._x000D_ 5: Azizi M, Guyene TT, Chatellier G, Wargon M, Ménard J. Additive effects of losartan and enalapril on blood pressure and plasma active renin Hypertension. 1997 Feb;29(2):634-40._x000D_ 6: Hall WD. Hypertension in the elderly with a special focus on treatment with angiotensin-converting enzyme inhibitors and calcium antagonists Am J Cardiol. 1992 Apr 30;69(13):33E-42E._x000D_ 7: Ménard J, Boger RS, Moyse DM, Guyene TT, Glassman HN, Kleinert HD. Dose-dependent effects of the renin inhibitor zankiren HCl after a single oral dose in mildly sodium-depleted normotensive subjects Circulation. 1995 Jan 15;91(2):330-8._x000D_ 8: Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives Circulation. 1995 Aug 15;92(4):825-34._x000D_ 9: Cannella G, Galva MD, Campanini M, Cesura AM, De Marinis S, Picotti GB. Sequential changes in plasma renin activity and plasma catecholamines in mildly hypertensive patients during acute, furosemide-induced body-fluid loss Eur J Clin Pharmacol. 1983;25(3):299-302._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/8510388">10: Krishna GG, Kapoor SC. Potassium supplementation ameliorates mineralocorticoid-induced sodium retention Kidney Int. 1993 May;43(5):1097-103. </a>_x000D_ _x000D_ <strong>Products Related to Renin and Prorenin Depleted Human Plasma can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>